In light of the withdrawal of diclofenac from OTC sale in UK pharmacies over concerns about cardiovascular safety, it may be time to reconsider the role of the drug altogether.
Regulators and pharmaceutical companies are monitoring social media posts for potential adverse drug reaction signals.
Up to a million more people could be offered weight loss surgery on the NHS after NICE lowered the threshold for which patients are eligible for bariatric surgery. David Haslam, GP and chairman of the National Obesity Forum UK, and David Katz, director, Yale University Prevention Research Center, discuss the merits of the decision, and the use of ...
In her role as principal research fellow at the Drug Safety Research Unit, Deborah Layton uses principles of pharmacoepidemiology to develop studies to help assess the safety of drugs.
A new medicine that allows Parkinson’s disease patients to spend more of the day symptom-free has been recommended for approval in Europe.
The public trusts pharmacists but not to the same degree as other health professionals, survey showsSubscription
The public trusts the advice given by a community pharmacist but the degree of trust is lower than that afforded to other health professionals, according to an IPSOS/Mori poll.
FDA advice on metformin is curbing its useSubscription